| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $951.05K | $577.28K | $993.87K | $787.34K | $800.54K |
| R&D | – | – | – | – | – |
| SG&A | $207.22K | $146.64K | $148.62K | $185.37K | $155.50K |
| Operating Income | – | – | – | – | – |
| Interest Expense | $614.44K | $63.26K | $86.35K | $21.00K | $84.48K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | – | – | – | – | – |
| EPS (basic) | 0.0000 | -0.0100 | -0.0100 | -0.0100 | – |
| EPS (diluted) | 0.0000 | -0.0100 | -0.0100 | -0.0100 | – |
| Shares (diluted) | $594.56M | $529.47M | $490.31M | – | – |